文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

盆腔器官运动对宫颈癌IMRT靶区剂量的影响

Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer.
PubMed 文献 · Radiother Oncol · 2016-11-16

本研究回顾性分析10例宫颈癌放化疗患者的105次CBCT图像,评估器官充盈导致原发CTV位置变化对剂量的影响。结果显示部分分次出现CTV低剂量,计划膀胱体积>300cc者变异最大,重新计划可改善覆盖。建议计划时膀胱体积150-300cc,治疗时保持在计划体积-50cc至+150cc范围内。

要点

  • 计划膀胱体积>300cc者CTV剂量变异最大,重新计划可改善覆盖。
  • 膀胱体积在计划体积-50cc至+150cc时,93%分次D99>95%。
  • 前中子宫点覆盖最差,中位剂量98.7%,大膀胱体积时降至91.4%。

核心结论

  • 器官位置变化对原发CTV(包括宫颈)的剂量有不利影响。
  • 计划膀胱体积>300cc导致更大变异,重新计划可改善覆盖。
  • 建议计划时膀胱体积150-300cc,治疗时保持在计划体积-50cc至+150cc。

研究设计与样本

  • 回顾性分析10例接受宫颈癌放化疗患者的每周两次CBCT图像,共105次扫描。
  • 勾画原发CTV、膀胱和直肠,使用10-15mm CTV-PTV margin创建RapidArc计划。
  • 采用新型向量方法计算基于每次CBCT位置的CTV剂量,并分析中央子宫、中子宫和宫颈向量及特定点的剂量。
  • 对计划膀胱体积大的病例,使用膀胱体积150-300cc时的CTV创建额外RapidArc计划。

主要发现

  • 向量分析显示部分病例CTV低剂量:2例所有三个向量平均覆盖低于95%,1例一个向量低于95%。
  • 体积分析显示48%的分次D99<95%。
  • 计划膀胱体积>300cc的患者变异最大,重新计划改善了覆盖。
  • 前中子宫点覆盖最差,中位剂量98.7%,计划膀胱体积大时降至91.4%,重新计划显著改善。
  • 膀胱体积在计划体积-50cc至+150cc时,93%分次D99>95%,而超出此范围时仅24%;D95>95%分别为100%和84%。

关键数值与推荐

  • 计划膀胱体积>300cc与更大变异相关。
  • 膀胱体积在计划体积-50cc至+150cc时,93%分次D99>95%,24%分次在范围外。
  • D95>95%在范围内为100%,范围外为84%。
  • 前中子宫点中位剂量98.7%,大膀胱体积时91.4%。

临床怎么用

  • 计划时膀胱体积建议150-300cc。
  • 治疗时膀胱体积保持在计划体积-50cc至+150cc范围内。
  • 对计划膀胱体积大的患者考虑重新计划以改善CTV覆盖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Advanced radiotherapy techniques reduce normal tissue dose by conforming closely to target volumes. In cervical cancer radiotherapy, organ filling affects clinical target volume (CTV; cervix, uterus) position. This study estimates the dosimetric effect of this primary CTV position variation during chemoradiation. METHODS/MATERIALS: Twice weekly cone-beam computed tomography (CBCT) images of ten patients undergoing cervical chemoradiation were retrospectively analysed. Primary CTV, bladder and rectum were delineated. RapidArc plans were created using 10-15mm CTV-PTV margins and dose delivered to CTV based on each CBCT position was calculated using a novel vector approach. Dose delivered along the central uterine, mid-uterus and cervix vectors were analysed as well as dose delivered to points at uterine tip, anterior mid-uterus and anterior cervix. Additional RapidArc plans were created for large planning bladder volume cases using the CTV acquired with bladder volume at 150-300cc. RESULTS: 105 scans for 10 patients were analysed. Vector analysis revealed CTV underdosing in certain cases. Below 95% average vector coverage was found for all three vectors in 2 cases and one vector in 1 case. Volumetric analysis revealed D99<95% in 48% of fractions. Patients with large planning bladder volumes (>300cc) demonstrated the largest variation. Replanning improved this coverage. The anterior mid-uterus point was least well-covered; median 98.7% dose, reducing to 91.4% in cases with large planning bladder volumes. Again, replanning significantly improved this. D99>95% was maintained in 93% of fractions when bladder volume was 50cc below to 150cc above planning volume compared to 24% of fractions if bladder volume was outside this range. Similarly, D95>95% was 100% versus 84%. CONCLUSION: Organ position variation detrimentally affected dose delivered to CTV including cervix. Large planning bladder volumes (>300cc) led to more variation. We recommend bladder volumes of 150-300cc at planning and a range of 50cc below to 150cc above planning for treatment.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Eminowicz G, Rompokos V, Stacey C, et al. Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer. Radiother Oncol. 2016. PMID: 27863962. doi:10.1016/j.radonc.2016.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。